254 related articles for article (PubMed ID: 26980570)
1. Altered RNA editing in 3' UTR perturbs microRNA-mediated regulation of oncogenes and tumor-suppressors.
Zhang L; Yang CS; Varelas X; Monti S
Sci Rep; 2016 Mar; 6():23226. PubMed ID: 26980570
[TBL] [Abstract][Full Text] [Related]
2. Clinical Relevance of Noncoding Adenosine-to-Inosine RNA Editing in Multiple Human Cancers.
Gu T; Fu AQ; Bolt MJ; White KP
JCO Clin Cancer Inform; 2019 Jun; 3():1-8. PubMed ID: 31162949
[TBL] [Abstract][Full Text] [Related]
3. miR-93-directed downregulation of DAB2 defines a novel oncogenic pathway in lung cancer.
Du L; Zhao Z; Ma X; Hsiao TH; Chen Y; Young E; Suraokar M; Wistuba I; Minna JD; Pertsemlidis A
Oncogene; 2014 Aug; 33(34):4307-15. PubMed ID: 24037530
[TBL] [Abstract][Full Text] [Related]
4. Combinatory RNA-Sequencing Analyses Reveal a Dual Mode of Gene Regulation by ADAR1 in Gastric Cancer.
Cho CJ; Jung J; Jiang L; Lee EJ; Kim DS; Kim BS; Kim HS; Jung HY; Song HJ; Hwang SW; Park Y; Jung MK; Pack CG; Myung SJ; Chang S
Dig Dis Sci; 2018 Jul; 63(7):1835-1850. PubMed ID: 29691780
[TBL] [Abstract][Full Text] [Related]
5. ADAR1-mediated 3' UTR editing and expression control of antiapoptosis genes fine-tunes cellular apoptosis response.
Yang CC; Chen YT; Chang YF; Liu H; Kuo YP; Shih CT; Liao WC; Chen HW; Tsai WS; Tan BC
Cell Death Dis; 2017 May; 8(5):e2833. PubMed ID: 28542129
[TBL] [Abstract][Full Text] [Related]
6. Human cancer tissues exhibit reduced A-to-I editing of miRNAs coupled with elevated editing of their targets.
Pinto Y; Buchumenski I; Levanon EY; Eisenberg E
Nucleic Acids Res; 2018 Jan; 46(1):71-82. PubMed ID: 29165639
[TBL] [Abstract][Full Text] [Related]
7. A-to-I RNA editing shows dramatic up-regulation in osteosarcoma and broadly regulates tumor-related genes by altering microRNA target regions.
Ge F; Cao X; Jiang Y
J Appl Genet; 2023 Sep; 64(3):493-505. PubMed ID: 37542613
[TBL] [Abstract][Full Text] [Related]
8. RNA Editing Modulates Human Hepatic Aryl Hydrocarbon Receptor Expression by Creating MicroRNA Recognition Sequence.
Nakano M; Fukami T; Gotoh S; Takamiya M; Aoki Y; Nakajima M
J Biol Chem; 2016 Jan; 291(2):894-903. PubMed ID: 26601943
[TBL] [Abstract][Full Text] [Related]
9. Single nucleotide polymorphisms in microRNA binding sites of oncogenes: implications in cancer and pharmacogenomics.
Manikandan M; Munirajan AK
OMICS; 2014 Feb; 18(2):142-54. PubMed ID: 24286505
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-410 suppresses migration and invasion by targeting MDM2 in gastric cancer.
Shen J; Niu W; Zhou M; Zhang H; Ma J; Wang L; Zhang H
PLoS One; 2014; 9(8):e104510. PubMed ID: 25136862
[TBL] [Abstract][Full Text] [Related]
11. A-to-I RNA Editing Up-regulates Human Dihydrofolate Reductase in Breast Cancer.
Nakano M; Fukami T; Gotoh S; Nakajima M
J Biol Chem; 2017 Mar; 292(12):4873-4884. PubMed ID: 28188287
[TBL] [Abstract][Full Text] [Related]
12. The tumor suppressor microRNA let-7 represses the HMGA2 oncogene.
Lee YS; Dutta A
Genes Dev; 2007 May; 21(9):1025-30. PubMed ID: 17437991
[TBL] [Abstract][Full Text] [Related]
13. Landscape of tissue-specific RNA Editome provides insight into co-regulated and altered gene expression in pigs (
Adetula AA; Fan X; Zhang Y; Yao Y; Yan J; Chen M; Tang Y; Liu Y; Yi G; Li K; Tang Z
RNA Biol; 2021 Oct; 18(sup1):439-450. PubMed ID: 34314293
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-339-5p inhibits colorectal tumorigenesis through regulation of the MDM2/p53 signaling.
Zhang C; Liu J; Wang X; Wu R; Lin M; Laddha SV; Yang Q; Chan CS; Feng Z
Oncotarget; 2014 Oct; 5(19):9106-17. PubMed ID: 25193859
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-363 targets myosin 1B to reduce cellular migration in head and neck cancer.
Chapman BV; Wald AI; Akhtar P; Munko AC; Xu J; Gibson SP; Grandis JR; Ferris RL; Khan SA
BMC Cancer; 2015 Nov; 15():861. PubMed ID: 26545583
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA and microRNAs might act in regulating the expression of BARD1 mRNAs.
Pilyugin M; Irminger-Finger I
Int J Biochem Cell Biol; 2014 Sep; 54():356-67. PubMed ID: 25008968
[TBL] [Abstract][Full Text] [Related]
17. The 3'UTR of the pseudogene CYP4Z2P promotes tumor angiogenesis in breast cancer by acting as a ceRNA for CYP4Z1.
Zheng L; Li X; Gu Y; Lv X; Xi T
Breast Cancer Res Treat; 2015 Feb; 150(1):105-18. PubMed ID: 25701119
[TBL] [Abstract][Full Text] [Related]
18. ADAR1-mediated RNA-editing of 3'UTRs in breast cancer.
Sagredo EA; Blanco A; Sagredo AI; Pérez P; Sepúlveda-Hermosilla G; Morales F; Müller B; Verdugo R; Marcelain K; Harismendy O; Armisén R
Biol Res; 2018 Oct; 51(1):36. PubMed ID: 30290838
[TBL] [Abstract][Full Text] [Related]
19. MicroRNA-27a functions as an oncogene in gastric adenocarcinoma by targeting prohibitin.
Liu T; Tang H; Lang Y; Liu M; Li X
Cancer Lett; 2009 Jan; 273(2):233-42. PubMed ID: 18789835
[TBL] [Abstract][Full Text] [Related]
20. MiR-194, commonly repressed in colorectal cancer, suppresses tumor growth by regulating the MAP4K4/c-Jun/MDM2 signaling pathway.
Wang B; Shen ZL; Gao ZD; Zhao G; Wang CY; Yang Y; Zhang JZ; Yan YC; Shen C; Jiang KW; Ye YJ; Wang S
Cell Cycle; 2015; 14(7):1046-58. PubMed ID: 25602366
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
